Inducida por factores exógenos | 27 OCT 19

Dermatitis de contacto

La dermatitis de contacto representa el 70-90% de todas las enfermedades ocupacionales de la piel
11
27
Autor/a: Rabia Sofia Rashid Tang Ngee Shim Fuente: BMJ 2016;353:i3299  Contact dermatitis
INDICE:  1. Página 1 | 2. Referencias
Referencias

1 Adisesh A, Robinson E, Nicholson PJ, Sen D, Wilkinson M. Standards of Care Working Group. U.K. standards of care for occupational contact dermatitis and occupational contact urticaria. Br J Dermatol 2013;168:1167-75. doi:10.1111/bjd.12256 pmid:23374107.

2 Diepgen TL, Ofenloch RF, Bruze M, et al. Prevalence of contact allergy in the general

population in different European regions. Br J Dermatol 2016;174:319-29. doi:10.1111/bjd.14167 pmid:26370659.

3 Kadyk DL, McCarter K, Achen F, Belsito DV. Quality of life in patients with allergic contact dermatitis. J Am Acad Dermatol 2003;49:1037-48. doi:10.1016/S0190-9622(03)02112-1 pmid:14639382.

4 Boehm D, Schmid-Ott G, Finkeldey F, et al. Anxiety, depression and impaired health-related quality of life in patients with occupational hand eczema. Contact Dermat 2012;67:184-92doi:10.1111/j.1600-0536.2012.02062.x.

5 Holness DL, Beaton D, Harniman E, et al. Hand and upper extremity function in workers with hand dermatitis. Dermatitis 2013;24:131-6. doi:10.1097/DER. 0b013e3182910416 pmid:23665832.

6 Tan CH, Rasool S, Johnston GA. Contact dermatitis: allergic and irritant. Clin Dermatol 2014;32:116-24. doi:10.1016/j.clindermatol.2013.05.033 pmid:24314385.

7 Pigatto PD. Conctact dermatitis: some important topics. Eur Ann Allergy Clin Immunol 2015;47:188-91.pmid:26549335.

8 Fonacier L, Bernstein DI, Pacheco K, et al. American Academy of Allergy, Asthma & Immunology American College of Allergy, Asthma & Immunology Joint Council of Allergy, Asthma & Immunology. Contact dermatitis: a practice parameter-update 2015. J Allergy Clin Immunol Pract 2015;3(Suppl):S1-39. doi:10.1016/j.jaip.2015.02.009 pmid:25965350.

9 Fonacier LS, Sher JM. Allergic contact dermatitis. Ann Allergy Asthma Immunol 2014;113:9-12. doi:10.1016/j.anai.2014.03.018 pmid:24950843.

10 American Academy of Allergy, Asthma and Immunology American College of Allergy, Asthma and Immunology. Contact dermatitis: a practice parameter. Ann Allergy Asthma Immunol 2006;97(Suppl 2):S1-38. doi:10.1016/S1081-1206(10)60811-3 pmid:17039663.

11 Kalish RS. Recent developments in the pathogenesis of allergic contact dermatitis. Arch Dermatol 1991;127:1558-63. doi:10.1001/archderm.1991.01680090122016 pmid:1929465.

12 McFadden JP, Puangpet P, Basketter DA, Dearman RJ, Kimber I. Why does allergic contact dermatitis exist?Br J Dermatol 2013;168:692-9. doi:10.1111/bjd.12145 pmid: 23383741.

13 Burkemper NM. Contact dermatitis, patch testing and allergen avoidance. Mo Med 2015;112:296-300.pmid:26455061.

14 Bourke J, Coulson I, English J. British Association of Dermatologists Therapy Guidelines and Audit Subcommittee. Guidelines for the management of contact dermatitis: an update. Br J Dermatol 2009;160:946-54. doi:10.1111/j.1365-2133.2009.09106.x pmid:19302065. 15 Aerts O, Baeck M, Constandt L, et al. The dramatic increase in the rate of methylisothiazolinone contact allergy in Belgium: a multicentre study. Contact Dermatitis 2014;71:41-8. doi:10.1111/cod.12249 pmid:24815516.

16 Kohl L, Blondeel A, Song M. Allergic contact dermatitis from cosmetics. Retrospective analysis of 819 patch-tested patients. Dermatology 2002;204:334-7. doi:10.1159/000063379 pmid:12077541.

17 Goldenberg A, Vassantachart J, Lin EJ, Lampel HP, Jacob SE. Nickel Allergy in Adults in the U.S.: 1962 to 2015. Dermatitis 2015;26:216-23. doi:10.1097/DER. 0000000000000130 pmid:26177034.

18 Health and Safety Executive. Work-related skin disease in Great Britain in 2014. www. hse.gov.uk/statistics/causdis/dermatitis.

19 Malik M, English J. Irritant hand dermatitis in health care workers. Occup Med (Lond) 2015;65:474-6. doi:10.1093/occmed/kqv067 pmid:26070815.

20 Thyssen JP, Johansen JD, Linneberg A, Menné T. The epidemiology of hand eczema in the general population--prevalence and main findings. Contact Dermatitis 2010;62:75-87. doi:10.1111/j.1600-0536.2009.01669.x pmid:20136890.

21 de Waard-van der Spek FB, Andersen KE, Darsow U, et al. Allergic contact dermatitis in children: which factors are relevant? (review of the literature). Pediatr Allergy Immunol 2013;24:321-9. doi:10.1111/pai.12043 pmid:23373713.

22 Admani S, Jacob SE. Allergic contact dermatitis in children: review of the past decade. Curr Allergy Asthma Rep 2014;14:421. doi:10.1007/s11882-014-0421-0 pmid:24504525.

23 Jakasa I, Verberk MM, Esposito M, Bos JD, Kezic S. Altered penetration of polyethylene glycols into uninvolved skin of atopic dermatitis patients. J Invest Dermatol 2007;127:129-34. doi:10.1038/sj.jid.5700582 pmid:17039242.

24 Aquino M, Fonacier L. The role of contact dermatitis in patients with atopic dermatitis. J Allergy Clin Immunol Pract 2014;2:382-7. doi:10.1016/j.jaip.2014.05.004 pmid:25017524.

25 Dooms-Goossens A, Morren M. Results of routine patch testing with corticosteroid series in 2073 patients. Contact Dermatitis 1992;26:182-91. doi:10.1111/j.1600-0536.1992. tb00290.x pmid:1505184.

26 Johansen JD, Hald M, Andersen BL, et al. Danish Contact Dermatitis Group. Classification of hand eczema: clinical and aetiological types. Based on the guideline of the Danish Contact Dermatitis Group. Contact Dermatitis 2011;65:13-21. doi:10.1111/j.1600-0536. 2011.01911.x pmid:21658054.

27 Johansen JD, Aalto-Korte K, Agner T, et al. European Society of Contact Dermatitis guideline for diagnostic patch testing - recommendations on best practice. Contact Dermatitis 2015;73:195-221. doi:10.1111/cod.12432 pmid:26179009.

28 Shehade SA, Beck MH, Hillier VF. Epidemiological survey of standard series patch test results and observations on day 2 and day 4 readings. Contact Dermatitis 1991;24:119-22. doi:10.1111/j.1600-0536.1991.tb01663.x pmid:2040153.

29 Higgins E, Collins P. The relevance of 7-day patch test reading. Dermatitis 2013;24:237-40. doi:10.1097/DER.0b013e31829cb0d1 pmid:24030365.

30 Thyssen JP, Skare L, Lundgren L, et al. Sensitivity and specificity of the nickel spot (dimethylglyoxime) test. Contact Dermatitis 2010;62:279-88. doi:10.1111/j.1600-0536. 2010.01709.x pmid:20536475.

31 Rajagopalan R, Anderson R. Impact of patch testing on dermatology-specific quality of life in patients with allergic contact dermatitis. Am J Contact Dermat 1997;8:215-21.pmid: 9417366.

32 Moustafa M, Holden CR, Athavale P, Cork MJ, Messenger AG, Gawkrodger DJ. Patch testing is a useful investigation in children with eczema. Contact Dermatitis 2011;65:208-12.

doi:10.1111/j.1600-0536.2011.01900.x pmid:21504435.

33 Jacob SE, Burk CJ, Connelly EA. Patch testing: another steroid-sparing agent to consider in children. Pediatr Dermatol 2008;25:81-7. doi:10.1111/j.1525-1470.2007.00589.x pmid: 18304161.

34 Hammonds LM, Hall VC, Yiannias JA. Allergic contact dermatitis in 136 children patch tested between 2000 and 2006. Int J Dermatol 2009;48:271-4. doi:10.1111/j.1365-4632. 2009.03890.x pmid:19261015.

35 Nethercott JR, Holness DL. Validity of patch test screening trays in the evaluation of patients with allergic contact dermatitis. J Am Acad Dermatol 1989;21:568. doi:10.1016/S0190-9622(89)80228-2 pmid:2778117.

36 Basketter DA, White IR. Diagnostic patch testing--does it have a wider relevance?Contact Dermatitis 2012;67:1-2. doi:10.1111/j.1600-0536.2012.02131.x pmid:22681461.

37 White JML. Patch testing: what allergists should know. Clin Exp Allergy 2012;42:180-5. doi:10.1111/j.1365-2222.2011.03862.x pmid:22092850.

38 Jonker MJ, Bruynzeel DP. Anaphylactic reaction elicited by patch testing with diclofenac. Contact Dermatitis 2003;49:114-5. doi:10.1111/j.0105-1873.2003.0128m.x pmid:14641371.

39 Warshaw EM, Maibach HI, Taylor JS, et al. North American contact dermatitis group patch test results: 2011-2012. Dermatitis 2015;26:49-59. doi:10.1097/DER. 0000000000000097 pmid:25581671.

40 Lurati AR. Occupational risk assessment and irritant contact dermatitis. Workplace Health Saf 2015;63:81-7, quiz 88. doi:10.1177/2165079914565351 pmid:25881659.

41 Hannuksela M, Salo H. The repeated open application test (ROAT). Contact Dermatitis 1986;14:221-7. doi:10.1111/j.1600-0536.1986.tb01229.x pmid:2941220.

42 Kasemsarn P, Bosco J, Nixon RL. The role of the skin barrier in occupational skin diseases. Curr Probl Dermatol 2016;49:135-43. doi:10.1159/000441589 pmid:26844905.

43 Williams C, Wilkinson SM, McShane P, et al. A double-blind, randomized study to assess the effectiveness of different moisturizers in preventing dermatitis induced by hand washing to simulate healthcare use. Br J Dermatol 2010;162:1088-92. doi:10.1111/j.1365-2133. 2010.09643.x pmid:20199550.

44 Held E, Lund H, Agner T. Effect of different moisturizers on SLS-irritated human skin. Contact Dermatitis 2001;44:229-34. doi:10.1034/j.1600-0536.2001.044004229.x pmid: 11260239.

45 Bauer A, Schmitt J, Bennett C, et al. Interventions for preventing occupational irritant hand dermatitis. Cochrane Database Syst Rev 2010;(6):CD004414.pmid:20556758.

46 Cohen DE, Heidary N. Treatment of irritant and allergic contact dermatitis. Dermatol Ther 2004;17:334-40. doi:10.1111/j.1396-0296.2004.04031.x pmid:15327479.

47 Diepgen TL, Andersen KE, Chosidow O, et al. Guidelines for diagnosis, prevention and treatment of hand eczema. J Dtsch Dermatol Ges 2015;13:e1-22. doi:10.1111/ddg.12510_ 1 pmid:25763418.

48 English J, Aldridge R, Gawkrodger DJ, et al. Consensus statement on the management of chronic hand eczema. Clin Exp Dermatol 2009;34:761-9. doi:10.1111/j.1365-2230. 2009.03649.x pmid:19747339.

49 Veien NK, Olholm Larsen P, Thestrup-Pedersen K, Schou G. Long-term, intermittent treatment of chronic hand eczema with mometasone furoate. Br J Dermatol 1999;140:882-6. doi:10.1046/j.1365-2133.1999.02819.x pmid:10354026.

50 Möller H, Svartholm H, Dahl G. Intermittent maintenance therapy in chronic hand eczema with clobetasol propionate and flupredniden acetate. Curr Med Res Opin 1983;8:640-4. doi:10.1185/03007998309109812 pmid:6365465.

51 National Institute for Health and Clinical Excellence. Tacrolimus and pimecrolimus for atopic eczema (NICE technology appraisal guidance TA82). 2004. www.nice.org.uk/guidance/TA82.

52 Ashcroft DM, Dimmock P, Garside R, Stein K, Williams HC. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials. BMJ 2005;330:516. doi:10.1136/bmj.38376.439653. D3 pmid:15731121.

53 Katsarou A, Makris M, Papagiannaki K, Lagogianni E, Tagka A, Kalogeromitros D. Tacrolimus 0.1% vs mometasone furoate topical treatment in allergic contact hand eczema: a prospective randomized clinical study. Eur J Dermatol 2012;22:192-6.pmid:22407003.

54 National Institute for Health and Clinical Excellence. Alitretinoin for treatment of severe chronic hand eczema (NICE technology appraisal guidance TA177). 2009. www.nice.org.uk/guidance/ta177.

55 Mälkönen T, Alanko K, Jolanki R, et al. Long-term follow-up study of occupational hand eczema. Br J Dermatol 2010;163:999-1006. doi:10.1111/j.1365-2133.2010.09987.x pmid:20716224.

 

Comentarios

Usted debe ingresar al sitio con su cuenta de usuario IntraMed para ver los comentarios de sus colegas o para expresar su opinión. Si ya tiene una cuenta IntraMed o desea registrase, ingrese aquí